Transcription of 795 PHARMACEUTICAL COMPOUNDING—NONSTERILE …
{{id}} {{{paragraph}}}
Example: bankruptcy
795 PHARMACEUTICAL COMPOUNDING—NONSTERILE …
Revision BulletinOfficial January 1, 2014 795 PHARMACEUTICAL Compounding Nonsterile Preparations1 Preparation of drugs or devices for the purposes of, or 795 PHARMACEUTICALas an incident to, research (clinical or academic),teaching, or chemical analysisCOMPOUNDING NONSTERILE Preparation of drugs and devices for prescriber s officeuse where permitted by federal and state lawPREPARATIONSHAZARDOUS DRUG Any drug identified by at least one ofthe following six criteria: Carcinogenicity Teratogenicity or developmental toxicity Reproductive toxicity in humansINTRODUCTION Organ toxicity at low doses in humans or animals GenotoxicityThe purpose of this chapter is to provide compounders New drugs that mimic existing hazardous drugs inwith guidance on applying good compounding practicesstructure or toxicity [for examples see current Nationalfor the preparation of nonsterile compounded formulationsInstitute for Occupational Safety and Health (NIOSH)for dispensing and/or administration to humans or ]Compounding is an integral part of pharmacy practice andMANUFACTURING The production, propagation, conversion,is essential to the provision of healthcare.
ric Apparatus 〈1176〉, Stability Considerations in Dispensing compounded. Practice 〈1191〉, Written Prescription Drug Information— 3. Ingredients used in the formulation have their ex-Guidelines 〈1265〉, and all applicable compounding laws, …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: